Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Windlas Biotech IPO.
August 16, 2021 5:48:00 PM
Devyani International IPO, Krsnaa Diagnostics IPO, Windlas Biotech IPO and Exxaro Tiles, which will make their debut on bourses today, have opened for subscription on August 4 and closed on August 6 ...
Published by : Zee BusinessMarch 15, 2024 9:37:00 AM
While there may be exceptions and individual stock performances can vary widely, the first-day trading behavior of IPOs often provides insight into the long-term prospects of the biotech sector.
Published by : The UBJ on MSNApril 10, 2024 3:30:00 AM
Windlas Biotech Ltd share price was down by -0.35% from the previous closing price of ?549.00. Who are peers of Windlas Biotech Ltd? The peers of Windlas Biotech Ltd are Sun Pharmaceuticals ...
Published by : Business TodayMarch 14, 2024 2:33:00 PM
with IPO funding of more than $1.2 billion so far this quarter still far below precrash levels, Jefferies data show. That might be a sign that conditions are ideal for investing in new biotech ...
Published by : The Wall Street Journal on MSNMarch 29, 2024 3:30:00 AM
It has shown the same promise among people with general obesity. The San Diego-based biotech is close to completing a pre-IPO financing round in which it will raise between $75mn and $100mn from a ...
Published by : The Financial TimesMarch 28, 2024 10:40:00 AM
Boundless Bio is bringing in $100 million from its IPO as the precision oncology company becomes the latest biotech to go public in 2024. The company has priced its 6.25 million shares at $16 ...
Published by : FierceBiotechApril 3, 2024 12:30:00 PM
The first quarter saw a hopeful glimmer in the IPO markets with a handful of companies announcing plans to take the plunge. The largest was CG Oncology, which had a total transaction value of $380 ...
Published by : FierceBiotechOctober 12, 2023 9:50:00 PM
After a decade of significant challenges, biotech's long-term sustainability depends on making fundamental changes to its traditional business model. A commonly held perception in the biotech ...
Published by : NatureMay 5, 2023 3:30:00 AM
The company raised $540 million from the sale of 30 million shares at $18 apiece, in the largest biotech IPO in the US since Sana Biotech went public in early 2021 with a $588 million raise that ...
Published by : pharmaphorumApril 4, 2024 3:30:00 AM
Contineum�s offering keeps biotech IPOs on their strongest pace in three years, according to BioPharma Dive data. By this time last year, only four drug startups had gone public, raising $375 ...
Published by : Yahoo FinanceMarch 29, 2024 3:30:00 AM
the latest biotech IPO, and intrigue over Chinese outsourcing. Damian Garde covers biotech, is a co-writer of The Readout newsletter, and a co-host of "The Readout LOUD" podcast.
Published by : STATMarch 21, 2024 6:34:00 PM
Laura Chico, Senior VP at Wedbush, is optimistic about 2024 biotech IPO market and M&A trends. As the U.S. heads into an election year, the biotech sector often faces uncertainty that can impact ...
Published by : Benzinga.comThe IPO Shares of Windlas Biotech Limited IPO are proposed to list on Monday, August 16, 2021 at BSE, NSE. The public issue of Windlas Biotech IPO was opened on Aug 4, 2021 and closed for subscription on Aug 6, 2021. Windlas Biotech IPO Listing Date and Information:
| Listing Date | Monday, August 16, 2021 |
| BSE Script Code | 543329 |
| NSE Symbol | WINDLAS |
| Listing In | |
| ISIN | INE0H5O01029 |
| Issue Price | ₹460 Per Equity Share |
| Face Value | ₹5 Per Equity Share |
The allotment status of Windlas Biotech Limited IPO is now available online. The public issue of Windlas Biotech IPO was open on Aug 4, 2021 and closed for subscription on Aug 6, 2021. The equity shares of the company to be list at BSE, NSE.
The issue of Windlas Biotech Limited opens on Aug 4, 2021 and closes for subscription on Aug 6, 2021. The equity shares of the company to be list at BSE, NSE. The price for the issue has been set at Rs 448- Rs 460 Per Equity Share.
Windlas Biotech Limited is entering in the capital market with an IPO of [.] Equity Shares of Rs 5 aggregating up to Rs 401.54 Crore. The price for the issue has been set at Rs 448-460 Rs Per Equity Share.
Incorporated in 2001, Windlas Biotech Ltd is one of the leading companies in the pharmaceutical formulations contract development and manufacturing organizations (CDMO) segment in India. The company offers a range of CDMO services from product discovery to product development, licensing, and commercial manufacturing of generic products including complex generics.
The issue opens on Aug 4, 2021 and closes for subscription on Aug 6, 2021. The equity shares of the company to be list at BSE, NSE.
The Windlas Biotech IPO is proposed to open on August 4, 2021. The IPO application ends on August 6, 2021.
Retail investors can apply in the retail or non-institutional investor category from August 4, 2021 to August 6, 2021. The Windlas Biotech IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Windlas Biotech IPO will open for subscription on August 4, 2021. The public issue will close on August 6, 2021.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
